We are live on ! Find out more
RAPT

RAPT Therapeutics
RAPT

Delisted

RAPT was delisted on the 2nd of March, 2026.

Back to rankings

78 hedge funds and large institutions have $468M invested in RAPT Therapeutics in 2021 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 19 increasing their positions, 27 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

376% more call options, than puts

Call options by funds: $16.6M | Put options by funds: $3.49M

16% more capital invested

Capital invested by funds: $404M → $468M (+$64.4M)

0.19% more ownership

Funds ownership: 10.41% → 10.61% (+0.19%)

0% more funds holding in top 10

Funds holding in top 10: 9 → 9 (0)

4% less funds holding

Funds holding: 81 → 78 (-3)

30% less repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 27

33% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 9

Holders
78
Holders Change
-3
Holders Change %
-3.7%
% of All Funds
1.37%
Holding in Top 10
9
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.16%
New
6
Increased
19
Reduced
27
Closed
9
Calls
$16.6M
Puts
$3.49M
Net Calls
+$13.1M
Net Calls Change
+$13.7M

Top Buyers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
+$18.5M
2
Millennium Management
Millennium Management
New York
+$1.53M
3
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board
Ontario, Canada
+$1.44M
4
Deutsche Bank
Deutsche Bank
Germany
+$931K
5
Two Sigma Advisers
Two Sigma Advisers
New York
+$530K

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$4.33M
2
ROTUOC
Regents of the University of California
California
-$2.52M
3
SSA
Schonfeld Strategic Advisors
New York
-$992K
4
Morgan Stanley
Morgan Stanley
New York
-$728K
5
KCM
Kingdon Capital Management
New York
-$610K
Name Holding Trade Value Shares
Change 		Change in
Stake
TD Asset Management
26
TD Asset Management
Ontario, Canada
$1.44M +$73.4K +445 +6%
Morgan Stanley
27
Morgan Stanley
New York
$1.32M -$728K -4,416 -37%
Two Sigma Advisers
28
Two Sigma Advisers
New York
$1.29M +$530K +3,213 +79%
Bank of New York Mellon
29
Bank of New York Mellon
New York
$1.03M -$11.7K -71 -1%
N
30
Nuveen
North Carolina
$934K -$36.9K -224 -4%
PHP
31
Parkman Healthcare Partners
Connecticut
$896K +$313K +1,899 +60%
Swiss National Bank
32
Swiss National Bank
Switzerland
$799K – – –
TRSOTSOK
33
Teachers Retirement System of the State of Kentucky
Kentucky
$789K +$221K +1,338 +43%
Two Sigma Investments
34
Two Sigma Investments
New York
$735K -$223K -1,350 -25%
PP
35
PDT Partners
New York
$687K +$426K +2,581 +200%
PCM
36
Pentwater Capital Management
Florida
$666K -$206K -1,250 -25%
ECM
37
ExodusPoint Capital Management
New York
$554K -$17.5K -106 -3%
California Public Employees Retirement System
38
California Public Employees Retirement System
California
$497K -$42.9K -260 -8%
Susquehanna International Group
39
Susquehanna International Group
Pennsylvania
$477K +$443K +2,688 New
HF
40
HRT Financial
New York
$472K +$439K +2,662 New
Los Angeles Capital Management
41
Los Angeles Capital Management
California
$390K +$362K +2,195 New
California State Teachers Retirement System (CalSTRS)
42
California State Teachers Retirement System (CalSTRS)
California
$367K – – –
QI
43
QS Investors
New York
$365K – – –
AG
44
Algert Global
California
$360K +$335K +2,029 New
State of Wisconsin Investment Board
45
State of Wisconsin Investment Board
Wisconsin
$351K – – –
AllianceBernstein
46
AllianceBernstein
Tennessee
$324K – – –
SCM
47
Sio Capital Management
New York
$317K – – –
WMRU
48
William Marsh Rice University
Texas
$316K – – –
Squarepoint
49
Squarepoint
New York
$279K -$319K -1,936 -55%
VEA
50
Virtus ETF Advisers
New York
$275K +$4.78K +29 +2%
1
2
3 4

RAPT Hedge Fund Activity: Q1 2021 in Review

78 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in RAPT Therapeutics (RAPT) for Q1 2021, worth a combined $468M — up 16% from $404M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of RAPT and 6 opened new positions — a net loss of 3 holders — while 27 trimmed existing stakes and 19 added.

The largest buyer was Perceptive Advisors, adding an estimated $18.5M. The largest seller was Wellington Management Group, cutting an estimated $4.33M.

  • 78 institutional investors held RAPT Therapeutics (RAPT) as of Q1 2021, down from 81 in Q4 2020.
  • Funds reported $468M of RAPT Therapeutics stock for Q1 2021, up 16% quarter-over-quarter.
  • 6 funds opened new RAPT Therapeutics positions in Q1 2021 and 9 closed out, a net change of -3 holders.
  • The largest RAPT Therapeutics buyer in Q1 2021 was Perceptive Advisors, an estimated $18.5M added.
  • The largest RAPT Therapeutics seller in Q1 2021 was Wellington Management Group, an estimated $4.33M sold.

Based on aggregated 13F filings for Q1 2021.